SB 819 (see companion bill HB 920) – Maryland

Status: Inactive / Dead
Year Introduced: 2019

Requiring the Secretary of Health, by a certain date each year, to identify a certain number of certain prescription drugs on which the State spends a certain amount of money; requiring the Secretary to require a certain pharmaceutical manufacturer to report certain cost changes and expenditures during a certain period of time; requiring the Secretary, by a certain date each year, to publish a report on the Maryland Department of Health’s website based on the information the Secretary receives under certain provisions of the Act; etc.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found